Literature DB >> 12399683

Alopecia areata during interferon alpha-2b/ribavirin therapy.

N Agesta, R Zabala, J L Díaz-Pérez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399683     DOI: 10.1159/000065841

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  6 in total

1.  Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.

Authors:  Robin Midian-Singh; Suresh Alagugurusamy; Radeshyam Agrawal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

Review 2.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.

Authors:  Nisha Mistry; Jonathan Shapero; Richard I Crawford
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

Review 3.  Antiviral drugs for viruses other than human immunodeficiency virus.

Authors:  Raymund R Razonable
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

4.  Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.

Authors:  Chi-Ming Li; Meirong Guo; Martha Salas; Nicole Schupf; Wayne Silverman; Warren B Zigman; Sameera Husain; Dorothy Warburton; Harshwardhan Thaker; Benjamin Tycko
Journal:  BMC Med Genet       Date:  2006-03-15       Impact factor: 2.103

5.  Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy.

Authors:  Kamuran Turker; Betul Tas; Murat Ozkaya; Ebru Tas; Aysel Caglar; Umit Seza Tetikkurt
Journal:  Hepat Mon       Date:  2015-03-20       Impact factor: 0.660

6.  Coexistence of Dermatomyositis and Alopecia Areata: Insight into Pathogenesis.

Authors:  Aashta Gupta; Pooja Arora; Ram K Gautam
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.